Anti-hepatitis B virus activities of natural products and their antiviral mechanisms

Chin J Nat Med. 2023 Nov;21(11):803-811. doi: 10.1016/S1875-5364(23)60505-9.

Abstract

Chronic hepatitis B (CHB) infections caused by the hepatitis B virus (HBV) continue to pose a significant global public health challenge. Currently, the approved treatments for CHB are limited to interferon and nucleos(t)ide analogs, both of which have their limitations, and achieving a complete cure remains an elusive goal. Therefore, the identification of new therapeutic targets and the development of novel antiviral strategies are of utmost importance. Natural products (NPs) constitute a class of substances known for their diverse chemical structures, wide-ranging biological activities, and low toxicity profiles. They have shown promise as potential candidates for combating various diseases, with a substantial number demonstrating anti-HBV properties. This comprehensive review focuses on the current applications of NPs in the fight against HBV and provides a summary of their antiviral mechanisms, considering their impact on the viral life cycle and host hepatocytes. By offering insights into the world of anti-HBV NPs, this review aims to furnish valuable information to support the future development of antiviral drugs.

Keywords: Antiviral stategy; Hepatitis B virus; Host hepatocyte; Life cycle; Mechanisms; Natural products.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Biological Products* / pharmacology
  • Biological Products* / therapeutic use
  • Hepatitis B virus
  • Hepatitis B, Chronic* / drug therapy
  • Hepatocytes
  • Humans

Substances

  • Antiviral Agents
  • Biological Products